EudociaQuant(Quant)LeeMD

PubMed

• 43 citations
  Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
  Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen
  Nature Communications. 2021-10-12
• 80 citations
  Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
  Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nan Lin
  Nature Medicine. 2020-08-01
• 562 citations
  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
  Patrick Y. Wen, Michael Weller, Eudocia Q. Lee, Brian M. Alexander, Jill S. Barnholtz-Sloan
  Neuro-Oncology. 2020-08-01

Lectures

• Barriers to accrual and enrollment in brain tumor trials. 
  2019 ASCO Annual Meeting - 6/1/2019

Other

• Anticoagulant and antiplatelet therapy in patients with brain tumors 
  Lee EQ, Wen PY
  http://www.uptodate.com/contents/anticoagulant-and-antiplatelet-therapy-in-patients-with-brain-tumor
  UpToDate, Wolters Kluwer Health - 2013-02-22
• Neurologic complications of cancer treatment with biologic agents 
  Lee EQ, Wen PY
  http://www.uptodate.com/contents/neurologic-complications-of-cancer-treatment-with-biologic-agents
  UpToDate, Wolters Kluwer Health - 2013-02-25
• Neurologic complications of non-platinum cancer chemotherapy 
  Lee EQ, Wen PY
  http://www.uptodate.com/contents/neurologic-complications-of-non-platinum-cancer-chemotherapy
  UpToDate, Wolters Kluwer Health - 2013-03-19
• Neurologic complications of platinum-based chemotherapy 
  Lee EQ, Wen PY
  http://www.uptodate.com/contents/neurologic-complications-of-platinum-based-chemotherapy
  UpToDate, Wolters Kluwer Health - 2012-12-21
• Join now to see all